Cargando…
Modulation of Cellular Mg(2+) Content in Cardiac Cells by α(1)-Adrenoceptor Stimulation and Anti-Arrhythmic Agents
Magnesium (Mg(2+)) is used pharmacologically to sedate specific forms of arrhythmias. Administration of pharmacological doses of catecholamine or adrenergic receptor agonists often results in arrhythmias onset. Results from the present study indicate that stimulation of cardiac adrenergic receptors...
Autor principal: | Romani, Andrea M.P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613808/ https://www.ncbi.nlm.nih.gov/pubmed/23092432 http://dx.doi.org/10.2174/1872208311206030212 |
Ejemplares similares
-
Cellular Mechanisms of the Anti-Arrhythmic Effect of Cardiac PDE2 Overexpression
por: Wagner, Michael, et al.
Publicado: (2021) -
New Progress in Understanding the Cellular Mechanisms of Anti-arrhythmic Drugs
por: An, Zhe, et al.
Publicado: (2018) -
Clock-Modulating Activities of the Anti-Arrhythmic Drug Moricizine
por: Han, Chorong, et al.
Publicado: (2021) -
In Vivo Stimulation of α- and β-Adrenoceptors in Mice Differentially Alters Small RNA Content of Circulating Extracellular Vesicles
por: Kwon, Jin-Sook, et al.
Publicado: (2021) -
Omega-3 Fatty Acids: Anti-Arrhythmic, Pro-Arrhythmic, or Both?
por: von Schacky, C.
Publicado: (2012)